DAWNRAYS PHARMA

2348
0.8950.56% ( -0.005 )
Delay Closed: Nov 16, 16:08:00

Financials

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: DAWNRAYS PHARMA(02348) the Revenue is 315.23 M (-8.73%);the EBIT is 66.83 M (+12.78%);the EPS is 0.0474 (+24.21%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.32B8.73%
----
----
EBIT
0.07B12.78%
----
----
EPS
0.047424.21%
----
----

Upcoming earnings report - FY2026 Q3 Earning Release

Available dateNov 27, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly